바이오모아 (BioMoa) — ADC · Antibody

9268프로그램 35FDA 승인

0오늘 방문

572누적 방문

8122갱신 대기 S–CData Tier S/A/B차세대 1068HER2 breast 5456Antibody 2744CGT →Psoriasis →NSCLC 35FDA 승인

피드 Data Tier 차세대

최근 활동

RSS →

ADCBiologicstaleImmunoGen, Inc.Phase 1

IMGN901 (IMGN901)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

효능 ORR 0.00%임상시험 6상태 ACTIVE

CGTBiologicCabaletta BioPhase 2

CABA-201 (CABA-201)

Relapsing Multiple Sclerosis (RMS); Progressive Multiple Sclerosis (PMS) · Pemphigus Vulgaris

#PemphigusVulgaris#CGT#Phase2#세포유전치료#CAR-T+5

임상시험 6상태 RECRUITING

ADCBiologicstaleGSKPhase 2

belantamab mafodotin (Blenrep, GSK2857916, Belantamab mafodotin lyophilized powder)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

효능 ORR 34%임상시험 6상태 ACTIVE

ADCBiologicstaleHoffmann-La RochePhase 2

Atirmociclib (Atirmociclib)

Metastatic Breast Cancer · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

임상시험 6상태 RECRUITING

ADCBiologicstaleRochePhase 2

Pola-R- GemOx (Polatuzumab Vedotin combined with Rituximab, Gemcitabine, and Oxaliplatin, Polatuzumab Vedotin combined with Rituximab, Gemcitabine, and Oxaliplatin (Pola-R- GemOx))

Diffuse Large B-Cell Lymphoma · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

효능 ORR 69.7%임상시험 6상태 RECRUITING

ADCBiologicAstraZenecasPhase 3

Sonesitatug vedotin (Sonesitatug vedotin)

Gastric Cancer; Gastroesophageal Junction Adenocarcinoma · Gastric Cancer

#GastricCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3

임상시험 6상태 RECRUITING

ADCBiologicstaleSenhwa Biosciences, Inc.Phase 1

Pidnarulex (Pidnarulex)

Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IV Breast Cancer AJCC v8 · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3

임상시험 6상태 RECRUITING

CGTBiologicstaleUSWM CT, LLCPhase 1

TCR-MAGE-A4 T-Cells (TCR-MAGE-A4 T-Cells)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#CGT#Phase1#세포유전치료#CAR-T+2

효능 ORR 0%임상시험 6상태 RECRUITING

CGTBiologicstaleNational Institutes of Health C…Phase 2

Individual Patient TCR Transduced PBL (Individual Patient TCR Transduced PBL)

Metastatic HPV-16 Positive Squamous Cell Anal Cancer · Multi-target

#Multi-target#CGT#Phase2#세포유전치료#CAR-T+3

임상시험 6상태 DISCONTINUED

CGTBiologicStephan Grupp MD PhDPhase 2

CART22-65s (Autologous, humanized anti-CD22 CAR T cell therapy, Autologous, humanized anti-CD22 CAR T cell therapy (CART22-65s))

B-cell Acute Lymphoblastic Leukemia; B Lineage Lymphoblastic Lymphoma · CD22

#CD22#CGT#Phase2#세포유전치료#CAR-T+5

임상시험 6상태 RECRUITING

AntibodystaleKite, A Gilead CompanyPhase 1

Lenzilumab (Lenzilumab)

Relapsed/Refractory Large B-cell Lymphoma · FRα

#FR#Antibody#Phase1#항체#면역항체+4

효능 ORR 9.9%임상시험 6상태 DISCONTINUED

ADCBiologicstaleTasly Pharmaceutical Group Co.,…Phase 2

STRO-002 (STRO-002)

Neoplasm Malignant · Ovarian Cancer

#OvarianCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 6상태 DISCONTINUED

CGTBiologicstaleiCell Gene TherapeuticsPhase 1

anti-CD5 CAR T cells (anti-CD5 CAR T cells)

T-cell Acute Lymphoblastic Leukemia; T-cell Non-Hodgkin Lymphoma · T-cell Acute Lymphoblastic Leukemia

#T-cellAcuteLymphoblasticLeukemia#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 6상태 ACTIVE

ADCBiologicstaleAstraZenecaPhase 2

AZD0901 (AZD0901)

Gastric Cancer; Gastroesophageal Junction Cancer · Gastric Cancer

#GastricCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 6상태 RECRUITING

CGTBiologicstalePersonGen BioTherapeutics (Suzh…Phase 1

T cell injection targeting CD7 chimeric antigen receptor (T cell injection targeting CD7 chimeric antigen receptor)

CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+4

임상시험 6상태 ACTIVE

CGTBiologicstaleCity of Hope Medical CenterPhase 1

CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes)

B Acute Lymphoblastic Leukemia; Recurrent Acute Lymphoblastic Leukemia · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+4

임상시험 6상태 RECRUITING

ADCBiologicstaleDaiichi SankyoPhase 1

DS-6000a (DS-6000a)

Renal Cell Carcinoma; Ovarian Tumor · Renal Cell Carcinoma

#RenalCellCarcinoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2

임상시험 6상태 RECRUITING

CGTBiologicstaleShanghai AbelZeta Ltd.Phase 1

C-CAR011 (C-CAR011)

Refractory or Relapsed B-cell Non-Hodgkin Lymphoma · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 6상태 ACTIVE

ADCBiologicstaleBase Therapeutics (Shanghai) Co…Phase 2

NK510 (NK510)

NSCLC · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 6상태 RECRUITING

CGTAAVBiologicstaleBrain Neurotherapy Bio, Inc.Phase 1

AAV2-GDNF gene therapy (AAV2-GDNF gene therapy)

Multiple System Atrophy · Multiple System Atrophy

#MultipleSystemAtrophy#CGT#Phase1#세포유전치료#CAR-T+2

임상시험 6상태 RECRUITING

ADCBiologicstaleAstraZenecaPreclinical

TDxd (TDxd)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+1

임상시험 6상태 RECRUITING

CGTBiologicstaleCity of Hope Medical CenterPhase 1

CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem T-lymphocytes (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem T-lymphocytes)

Central Nervous System Lymphoma · EGFR

#EGFR#CGT#Phase1#세포유전치료#CAR-T+3

임상시험 6상태 RECRUITING

ADCBiologicstaleSorrento Therapeutics, Inc.Phase 2

STI-6129 (STI-6129)

Advanced Solid Tumor · Light Chain (AL) Amyloidosis

#LightChainALAmyloidosis#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 6상태 ACTIVE

CGTAAVBiologicstaleBrain Neurotherapy Bio, Inc.Phase 1

AAV2-GDNF (AAV2-GDNF)

Parkinson's Disease · Parkinson's Disease

#ParkinsonsDisease#CGT#Phase1#세포유전치료#CAR-T+2

임상시험 6상태 RECRUITING

ADCBiologicstaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin Plus Cadonilimab)

Bile Duct Adenocarcinoma Non-Resectable; HER2 Gene Mutation · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

임상시험 6상태 ACTIVE

41 / 167 페이지

← 이전 다음 →

전체 9,268개 프로그램 보기

갱신 기록 없음 · 14일 주기 · 방문 0 / 572

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

IMGN901 (IMGN901)

CABA-201 (CABA-201)

belantamab mafodotin (Blenrep, GSK2857916, Belantamab mafodotin lyophilized powder)

Atirmociclib (Atirmociclib)

Pola-R- GemOx (Polatuzumab Vedotin combined with Rituximab, Gemcitabine, and Oxaliplatin, Polatuzumab Vedotin combined with Rituximab, Gemcitabine, and Oxaliplatin (Pola-R- GemOx))

Sonesitatug vedotin (Sonesitatug vedotin)

Pidnarulex (Pidnarulex)

TCR-MAGE-A4 T-Cells (TCR-MAGE-A4 T-Cells)

Individual Patient TCR Transduced PBL (Individual Patient TCR Transduced PBL)

CART22-65s (Autologous, humanized anti-CD22 CAR T cell therapy, Autologous, humanized anti-CD22 CAR T cell therapy (CART22-65s))

Lenzilumab (Lenzilumab)

STRO-002 (STRO-002)

anti-CD5 CAR T cells (anti-CD5 CAR T cells)

AZD0901 (AZD0901)

T cell injection targeting CD7 chimeric antigen receptor (T cell injection targeting CD7 chimeric antigen receptor)

CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes)

DS-6000a (DS-6000a)

C-CAR011 (C-CAR011)

NK510 (NK510)

AAV2-GDNF gene therapy (AAV2-GDNF gene therapy)

TDxd (TDxd)

CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem T-lymphocytes (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem T-lymphocytes)

STI-6129 (STI-6129)

AAV2-GDNF (AAV2-GDNF)

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin Plus Cadonilimab)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

IMGN901 (IMGN901)

CABA-201 (CABA-201)

belantamab mafodotin (Blenrep, GSK2857916, Belantamab mafodotin lyophilized powder)

Atirmociclib (Atirmociclib)

Pola-R- GemOx (Polatuzumab Vedotin combined with Rituximab, Gemcitabine, and Oxaliplatin, Polatuzumab Vedotin combined with Rituximab, Gemcitabine, and Oxaliplatin (Pola-R- GemOx))

Sonesitatug vedotin (Sonesitatug vedotin)

Pidnarulex (Pidnarulex)

TCR-MAGE-A4 T-Cells (TCR-MAGE-A4 T-Cells)

Individual Patient TCR Transduced PBL (Individual Patient TCR Transduced PBL)

CART22-65s (Autologous, humanized anti-CD22 CAR T cell therapy, Autologous, humanized anti-CD22 CAR T cell therapy (CART22-65s))

Lenzilumab (Lenzilumab)

STRO-002 (STRO-002)

anti-CD5 CAR T cells (anti-CD5 CAR T cells)

AZD0901 (AZD0901)

T cell injection targeting CD7 chimeric antigen receptor (T cell injection targeting CD7 chimeric antigen receptor)

CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes)

DS-6000a (DS-6000a)

C-CAR011 (C-CAR011)

NK510 (NK510)

AAV2-GDNF gene therapy (AAV2-GDNF gene therapy)

TDxd (TDxd)

CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem T-lymphocytes (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem T-lymphocytes)

STI-6129 (STI-6129)

AAV2-GDNF (AAV2-GDNF)

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin Plus Cadonilimab)

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

추천 비교

최근 활동

빠른 검색 · 이슈 태그

실시간 이슈 · 검색

IMGN901 (IMGN901)

CABA-201 (CABA-201)

belantamab mafodotin (Blenrep, GSK2857916, Belantamab mafodotin lyophilized powder)

Atirmociclib (Atirmociclib)

Pola-R- GemOx (Polatuzumab Vedotin combined with Rituximab, Gemcitabine, and Oxaliplatin, Polatuzumab Vedotin combined with Rituximab, Gemcitabine, and Oxaliplatin (Pola-R- GemOx))

Sonesitatug vedotin (Sonesitatug vedotin)

Pidnarulex (Pidnarulex)

TCR-MAGE-A4 T-Cells (TCR-MAGE-A4 T-Cells)

Individual Patient TCR Transduced PBL (Individual Patient TCR Transduced PBL)

CART22-65s (Autologous, humanized anti-CD22 CAR T cell therapy, Autologous, humanized anti-CD22 CAR T cell therapy (CART22-65s))

Lenzilumab (Lenzilumab)

STRO-002 (STRO-002)

anti-CD5 CAR T cells (anti-CD5 CAR T cells)

AZD0901 (AZD0901)

T cell injection targeting CD7 chimeric antigen receptor (T cell injection targeting CD7 chimeric antigen receptor)

CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes (CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes)